Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships

Journal of Medicinal Chemistry
1991.0

Abstract

The conformation of perindoprilat, an antihypertensive drug, is studied in the solid state by X-ray analysis. The resolution of its structure reveals important analogies between its observed conformation and that of several ACE inhibitors of the same family. This comparison points out a constant relative orientation of the functional groups, regardless of the molecular environment. This angular constancy appears to us as not being accidental and is a good argument for the spatial design of the ACE binding site. Although ACE is a carboxydipeptidase, the binding site may not contain two but one unique hydrophobic pocket receiving the C-terminal end of the inhibitors.

Knowledge Graph

Similar Paper

Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships
Journal of Medicinal Chemistry 1991.0
Molecular and crystal structures of MDL27,467A hydrochloride and quinapril hydrochloride, two ester derivatives of potent angiotensin converting enzyme inhibitors
Journal of Medicinal Chemistry 1991.0
Conformational analysis and active site modeling of angiotensin-converting enzyme inhibitors
Journal of Medicinal Chemistry 1985.0
Conformationally restricted inhibitors of angiotensin-converting enzyme. Synthesis and computations
Journal of Medicinal Chemistry 1986.0
The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme
Bioorganic & Medicinal Chemistry Letters 2006.0
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types
Journal of Medicinal Chemistry 1986.0
Angiotensin-converting enzyme inhibitors. Perhydro-1,4-thiazepin-5-one derivatives
Journal of Medicinal Chemistry 1987.0
Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives
Journal of Medicinal Chemistry 1988.0
Angiotensin-converting enzyme inhibitors: importance of the amide carbonyl of mercaptoacyl amino acids for hydrogen bonding to the enzyme
Journal of Medicinal Chemistry 1982.0
Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-[3-(Acylthio)-3-aroylpropionyl]-L-prolines
Journal of Medicinal Chemistry 1983.0